info icon

Renal cell carcinoma of kidney

C3_RENAL_CELL_CARCINOMA

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cancer registry: Topography ICD-O-3 C64
  • Cancer registry: Morphology ICD-O-3 8312|831[6-9]
  • Cancer registry: Behaviour codes 3

1 out of 7 registries used, show all original rules.

1265

4. Check minimum number of events

None

1265

5. Include endpoints

None

1265

6. Filter based on genotype QC (FinnGen only)

1265

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF8

Similar endpoints

List of similar endpoints to Renal cell carcinoma of kidney based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 1265 474 791
Unadjusted period prevalence (%) 0.28 0.16 0.35
Median age at first event (years) 63.23 60.73 64.72

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1178
Matched controls
11774
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
80.0
323.0
574
138
KAC10
NOMESCO Finland
Total nephrectomy with capsule
243.8
323.0
413
26
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
172.2
323.0
334
27
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
687.5
323.0
1021
108
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
323.0
1013
*
8317/3-C64.9
ICD-O-3
Renal cell carcinoma, chromophobe type of kidney, NOS
+∞
161.2
151
*
7125
FHL
Nephrectomy (extrrafascial)
1580.2
146.0
139
*
KAC11
NOMESCO Finland
Total nephrectomy with capsule, transcutaneous
70.3
129.7
148
24
197
Kela drug reimbursment
Sunitinib
141.3
109.2
115
9
1890B
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,ADENOCARCINOMA]
1101.7
104.9
101
*
L01XE04
ATC
[U] sunitinib; oral
230.1
103.3
105
5
KAC00
NOMESCO Finland
Nephrectomy
80.5
98.2
110
15
130
Kela drug reimbursment
Malignant tumour
5.9
98.2
310
667
C64.80
ICD-10 Finland
Wilms tumour
126.5
97.7
104
9
KAD00
NOMESCO Finland
Partial nephrectomy
72.6
93.3
106
16
180
Kela drug reimbursment
Interferon alfa
73.6
83.8
95
14
KAD01
NOMESCO Finland
Percutaneous endoscopic partial nephrectomy
54.9
69.2
82
16
JN4AD
NOMESCO Finland
Body CT examination
4.8
57.6
212
515
U75
ICPC
Malignant neoplasm of kidney
84.6
57.6
64
8
1890X
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,EI HIST VAHV]
+∞
53.5
51
*
C648
ICD-10 Finland
NA
+∞
52.5
50
*
1502
Kela drug reimbursment
Cabozantinib
80.8
48.3
54
7
3012
Kela drug reimbursment
Cabozantinib
79.3
47.3
53
7
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
14.0
45.5
79
60
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.3
44.2
256
910
322
Kela drug reimbursment
Sunitinib
122.2
44.1
47
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
20.5
44.0
66
34
JN4BD
NOMESCO Finland
Extensive body CT
3.4
42.5
237
817
159
Kela drug reimbursment
Pazopanib
59.7
39.5
46
8
158
Kela drug reimbursment
Everolimus
201.4
38.0
39
*
JN4CD
NOMESCO Finland
Very extensive body CT
5.0
35.1
118
255
L01XE26
ATC
[U] cabozantinib; oral
185.4
34.9
36
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
5.8
33.8
99
182
B01AB10
ATC
tinzaparin; parenteral
3.9
32.4
144
408
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.5
32.3
166
531
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
8.8
32.1
70
84
N02AX02
ATC
tramadol; systemic, rectal
2.1
31.6
585
3778
L01XE11
ATC
[U] pazopanib; oral
52.9
30.5
36
7
L03AA04
ATC
NA
49.9
28.5
34
7
KA1AE
NOMESCO Finland
Kidney ultrasound examination
6.7
27.4
71
111
D30.0
ICD-10 Finland
Benign neoplasm: Kidney
13.1
27.3
48
38
18900
ICD-8 Finland
Malignant neoplasm of other and unspecified urinary organs, Kidney, except pelvis
+∞
26.1
25
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
5.8
24.3
70
126
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.7
24.0
110
319
2395A
ICD-9 Finland
Neoplasm of unspecified nature, Other genito-urinary organs
34.1
23.4
30
9
L01EX07
ATC
cabozantinib; oral
45.9
22.4
27
6
L03AB05
ATC
interferon alfa-2b; parenteral
24.4
22.2
31
13
A03FA01
ATC
metoclopramide; systemic, rectal
2.1
21.5
288
1569
KA3LT
NOMESCO Finland
Njurlesion coagulation
44.2
21.5
26
6
A11CC03
ATC
alfacalcidol; systemic
5.5
21.3
64
122
168
Kela drug reimbursment
Axitinib
112.0
20.6
22
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
4.0
20.1
82
215
L03AB04
ATC
interferon alfa-2a; parenteral
29.5
19.7
26
9
L01XE10
ATC
[U] everolimus; oral
106.8
19.6
21
*
198
Kela drug reimbursment
Sorafenib
34.9
18.9
24
7
A12AA04
ATC
calcium carbonate; oral
6.7
17.3
44
68
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
17.1
330
2040
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
5.1
16.7
53
108
340
Kela drug reimbursment
Everolimus
+∞
16.7
16
*
1890A
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,NEPHROBLASTOMA]
+∞
16.7
16
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
3.8
16.7
72
199
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.9
16.5
104
380
TK800
NOMESCO Finland
Hemodialysis
5.3
16.2
49
95
B01AB05
ATC
enoxaparin; parenteral
1.7
15.7
392
2619
N18.8
ICD-10 Finland
Other chronic renal failure
3.7
15.6
68
190
Z49.0
ICD-10 Finland
Preparatory care for dialysis
8.9
15.3
32
37
N02AA05
ATC
oxycodone; systemic
1.9
15.2
235
1337
M04AA01
ATC
allopurinol; systemic
2.0
15.0
226
1269
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
8.4
14.8
32
39
L01XE17
ATC
[U] axitinib; oral
81.1
14.6
16
*
R31
ICD-10 Finland
Unspecified haematuria
2.1
14.5
188
995
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
4.6
14.3
49
109
U14
ICPC
Kidney symptom/complaint
6.1
13.8
37
62
L01XE05
ATC
[U] sorafenib; oral
28.7
13.0
17
6
343
Kela drug reimbursment
Pazopanib
50.6
12.9
15
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
4.2
12.7
47
114
205
Kela drug reimbursment
Chronic hypertension
1.6
12.5
441
3197
PHE70
NOMESCO Finland
Thrombectomy of inferior vena cava
+∞
12.5
12
*
N18.0
ICD-10 Finland
End-stage renal disease
5.9
12.4
34
59
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
12.2
363
2514
L02AB02
ATC
medroxyprogesterone; systemic (progestogens)
11.2
12.0
22
20
TPH07
NOMESCO Finland
Cathetrisation of artery
2.0
11.8
155
822
C08CA01
ATC
amlodipine; oral
1.6
11.7
475
3553
361
Kela drug reimbursment
Axitinib
65.6
11.6
13
*
JN3AD
NOMESCO Finland
Abdominal CT examination
2.3
11.6
109
497
Z49.1
ICD-10 Finland
Extracorporeal dialysis
5.7
11.5
32
57
R50.9
ICD-10 Finland
Fever, unspecified
2.0
11.3
164
901
V03AE01
ATC
polystyrene sulfonate; oral
5.0
11.2
35
72
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
11.2
535
4142
137
Kela drug reimbursment
Uraemia requiring dialysis
8.1
11.1
24
30
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.0
10.9
140
732
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.5
10.9
85
352
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
3.9
10.6
43
114
L01EX01
ATC
sunitinib; oral
60.5
10.6
12
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.3
10.4
94
421
WZC30
NOMESCO Finland
Teaching
1.9
10.2
154
858
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
6.2
10.0
26
43
7124
FHL
Nephrectomy (simple
40.4
10.0
12
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
5.7
9.8
27
48
C03CA01
ATC
furosemide; systemic
1.5
9.8
458
3498
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
7.4
9.7
22
30
Z90.5
ICD-10 Finland
Acquired absence of kidney
55.4
9.7
11
*
UKC02
NOMESCO Finland
Cystoscopy
1.6
9.4
252
1683
KAC01
NOMESCO Finland
Percutaneous endoscopic nephrectomy
21.9
9.4
13
6
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
5.8
9.2
25
44
V03AE02
ATC
sevelamer; oral
11.6
9.1
16
14
B02AA02
ATC
tranexamic acid; systemic
1.9
9.0
130
714
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.5
8.8
324
2329
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
5.7
8.8
24
43
KA4AT
NOMESCO Finland
Cytology of kidney with ultrasound guidance
50.3
8.7
10
*
B05DA
ATC
Isotonic solutions
8.3
8.6
18
22
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
7.0
8.6
20
29
BCA30
NOMESCO Finland
Unilateral adrenalectomy
27.7
8.5
11
*
SPAT1153
SPAT
Removal of sutures
1.5
8.4
362
2696
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
5.9
8.3
22
38
B03XA02
ATC
darbepoetin alfa; parenteral
3.6
8.3
35
98
RD211
NOMESCO Finland
NA
2.7
8.1
53
202
NA049
NOMESCO Finland
Radiotherapy of methastasis in spine
33.6
8.1
10
*
AA049
NOMESCO Finland
Radiotherapy of metasthasis in the brain
33.6
8.1
10
*
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
10.1
8.0
15
15
GD1AD
NOMESCO Finland
Thorax CT examination
2.5
8.0
59
240
N02AA01
ATC
morphine; systemic, rectal
3.6
7.7
33
94
J01MA02
ATC
ciprofloxacin; systemic
1.4
7.7
457
3616
H02AB02
ATC
dexamethasone; systemic
1.9
7.6
115
644
KAC20
NOMESCO Finland
Nephroureterectomy
11.9
7.6
13
11
M907, C6488
ICD-10 Finland
NA
80.5
7.4
8
*
C02AC05
ATC
moxonidine; oral
2.2
7.4
71
329
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
2.3
7.3
63
277
D41.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Renal pelvis
6.9
7.3
17
25
Z51.5
ICD-10 Finland
Palliative care
2.0
7.3
91
475
Z31.5
ICD-10 Finland
Genetic counselling
3.1
7.1
37
123
TK820
NOMESCO Finland
Peritoneal dialysis
12.1
7.1
12
10
Z49.2
ICD-10 Finland
Other dialysis
6.7
6.8
16
24
GDA20
NOMESCO Finland
Excision of lesion of lung
40.3
6.8
8
*
JLC10
NOMESCO Finland
Distal pancreatectomy
16.8
6.7
10
6
KWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in urological surgery
16.8
6.7
10
6
Z85.5
ICD-10 Finland
Personal history of malignant neoplasm of urinary tract
16.8
6.7
10
6
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.5
6.7
50
205
B05DB
ATC
Hypertonic solutions
7.9
6.6
14
18
M05BA02
ATC
clodronic acid; systemic
5.9
6.6
17
29
E83.50
ICD-10 Finland
Hypercalcemia
4.4
6.5
22
51
2230A
ICD-9 Finland
Benign neoplasm of kidney and other urinary organs, Kidney, except pelvis
70.2
6.4
7
*
R93.4
ICD-10 Finland
Abnormal findings on diagnostic imaging of urinary organs
6.0
6.3
16
27
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
11.1
6.3
11
10
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
9.3
6.3
12
13
1891X
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Renal pelvis[NEOPLASMA MALIGNUM PELVIS RENIS,EI HIST VAHV]
+∞
6.3
6
*
7121
FHL
Removal of local change or renal resection (eg cyst)
+∞
6.3
6
*
8318/3-C64.9
ICD-O-3
Renal cell carcinoma, sarcomatoid of kidney, NOS
+∞
6.3
6
*
8316/3-C64.9
ICD-O-3
Cyst-associated renal cell carcinoma of kidney, NOS
+∞
6.3
6
*
C08CA13
ATC
lercanidipine; oral
1.6
6.2
161
1054
C68.9
ICD-10 Finland
Malignant neoplasm: Urinary organ, unspecified
26.8
6.2
8
*
B03XA01
ATC
erythropoietin; parenteral
4.5
6.2
20
45
C79.7
ICD-10 Finland
Secondary malignant neoplasm of adrenal gland
12.6
6.1
10
8
C07AB02
ATC
metoprolol; systemic
1.4
6.1
288
2166
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
3.2
6.0
29
92
M05BX04
ATC
denosumab; parenteral
2.1
6.0
67
335
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
5.2
6.0
17
33

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3020779) Urea [Moles/volume] in Serum or Plasma
252
1015
2.85
43.62
9.7
6.6
mmol/l
12.0
11.1
0.98
238
959
(3003458) Phosphate [Moles/volume] in Serum or Plasma
302
1446
2.43
36.13
8.6
5.4
mmol/l
1.1
1.0
3.75
277
1324
(4035726)
204
873
2.59
30.63
1.2
1.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
115
383
3.20
27.35
3.5
2.7
g/l
0.4
0.3
0.63
81
151
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
185
813
2.49
26.06
5.5
3.8
ng/l
133.2
100.4
2.74
163
695
(3035637) Corticotropin [Mass/volume] in Plasma
46
98
4.83
20.44
1.6
1.7
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
156
720
2.33
19.48
6.7
8.2
%
1.3
1.4
0.76
156
713
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
155
715
2.33
19.37
6.7
8.3
%
0.6
0.7
1.93
155
708
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
538
3879
1.67
17.12
4.6
3.5
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
219
1214
1.97
16.93
6.1
6.9
%
96.0
95.2
1.12
213
1168
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
153
757
2.16
16.05
3.9
3.1
ml/min/173m2
49.4
58.6
4.87
104
330
(3000991) Gas panel - Venous blood
174
934
2.00
14.64
8.4
7.7
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
350
2337
1.69
14.40
3.2
2.7
e6/l
2.9
4.5
5.04
316
2073
(40761535) Cells panel - Urine sediment
168
909
1.98
13.79
5.3
3.6
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
226
1355
1.81
13.51
6.0
6.7
kpa
5.1
5.1
0.29
219
1284
(3027801) Oxygen [Partial pressure] in Arterial blood
226
1356
1.81
13.48
6.0
6.7
kpa
12.8
11.7
2.52
218
1287
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
584
4475
1.57
13.43
4.8
4.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
225
1359
1.80
13.10
6.0
6.7
mmol/l
0.2
1.2
3.24
175
1041
(3024561) Albumin [Mass/volume] in Serum or Plasma
593
4585
1.55
12.94
7.3
4.8
g/l
34.0
34.5
1.10
558
4240
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
616
4804
1.55
12.92
10.4
5.9
mmol/l
1.2
1.2
1.39
580
4301
(3009214) Lutropin [Units/volume] in Serum or Plasma
45
139
3.32
12.12
1.3
1.3
u/l
22.2
9.2
2.55
34
104
(3012095) Magnesium [Moles/volume] in Serum or Plasma
259
1673
1.69
11.79
4.3
3.2
mmol/l
0.8
0.8
0.55
247
1548
(3020891) Body temperature
99
470
2.20
11.48
5.6
4.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
647
5255
1.47
10.25
12.6
6.8
mmol/l
1.2
1.2
0.53
556
4398
(3008152) Bicarbonate [Moles/volume] in Arterial blood
136
756
1.89
10.23
6.9
6.3
mmol/l
24.3
24.3
0.02
131
709
(3036481) Cortisol [Moles/volume] in Serum or Plasma
145
828
1.85
10.03
4.8
2.1
nmol/l
407.8
372.9
1.33
138
754
(3031040) Bacteria [#/volume] in Urine by Automated count
775
6553
1.47
9.78
6.2
5.0
e6/l
497.3
2268.8
1.22
18
130
(3019060) Gas panel - Arterial blood
142
814
1.84
9.70
4.4
4.2
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
62
259
2.47
9.66
2.8
2.9
mg/l
1.9
1.8
0.19
56
233
(3029937) Albumin [Presence] in Urine by Test strip
354
2573
1.52
9.58
6.4
4.4
estimate
0.0
0.0
0.50
112
822
(40768804) Tissue Pathology biopsy report
474
3657
1.47
9.57
2.4
2.3
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
11
11
10.08
9.55
1.9
1.5
ng/l
136.9
102.5
0.30
11
11
(3026493) Urate [Moles/volume] in Serum or Plasma
360
2641
1.51
9.28
4.0
2.8
umol/l
3612.0
8031.9
1.04
308
2223
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
205
1322
1.66
9.23
4.1
3.9
u/l
255.8
251.4
0.11
197
1245
(3044640) Blood type and Crossmatch panel - Blood
420
3205
1.46
8.81
2.8
2.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
292
2073
1.53
8.71
6.6
4.5
kg/l
1.0
1.0
0.08
40
309
(3018418) pH of Serum or Plasma
412
3139
1.46
8.69
7.7
4.0
ph
7.4
7.4
2.80
85
589
(3030467) Casts [#/volume] in Urine by Automated count
394
2982
1.47
8.58
4.0
3.4
e6/l
0.2
0.5
6.73
335
2335
(3002582) Erythrocytes [#/volume] in Urine
426
3278
1.45
8.49
4.3
3.5
e6/l
122.9
94.9
0.16
364
2617
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
454
3538
1.44
8.44
6.0
4.4
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
234
1596
1.57
8.32
4.2
2.5
g/l
2.1
2.2
6.00
218
1463
(36304419) Bacteria [Presence] in Urine
377
2843
1.46
8.32
4.1
3.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
466
3686
1.42
7.84
5.0
4.0
e6/l
79.8
117.7
0.46
387
2781
(3021601) Nitrite [Presence] in Urine by Test strip
560
4574
1.40
7.83
7.2
5.5
estimate
0.0
0.0
0.00
120
869
(3014111) Lactate [Moles/volume] in Serum or Plasma
158
996
1.67
7.72
6.2
6.5
mmol/l
1.1
1.4
6.07
152
951
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
221
1512
1.56
7.72
4.4
2.5
%
19.9
22.1
1.93
188
1283
(3009261) Glucose [Presence] in Urine by Test strip
565
4638
1.39
7.59
6.0
4.1
estimate
0.0
0.0
0.50
124
852
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
42
165
2.60
7.48
5.1
3.2
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
246
1740
1.51
7.35
4.2
2.5
umol/l
10.3
12.1
4.27
228
1596
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
398
3096
1.42
7.24
3.8
2.5
u/l
64.7
57.0
1.04
374
2847
(3035350) Ketones [Presence] in Urine by Test strip
556
4580
1.38
7.19
5.8
4.1
estimate
0.0
0.0
0.00
122
869
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
627
5277
1.37
7.05
10.6
6.2
umol/l
11.1
12.4
0.85
601
4991
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
798
8891
0.72
6.92
6.0
5.0
mmol/l
6.1
6.1
0.19
721
7876
(3013650) Neutrophils [#/volume] in Blood by Automated count
635
5366
1.37
6.91
12.7
8.8
e9/l
4.3
4.3
0.11
569
4649
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
131
814
1.68
6.76
1.8
1.7
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
101
589
1.78
6.53
8.1
9.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
320
2438
1.42
6.43
2.9
2.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
186
1278
1.53
6.32
14.8
8.8
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
843
7503
1.37
6.32
13.3
7.6
u/l
80.9
81.2
0.07
805
6977
(3015736) pH of Urine
443
3583
1.36
6.17
5.5
3.8
—
6.1
—
0
5
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
78
428
1.88
6.15
4.3
3.3
pmol/l
4.2
4.4
0.40
67
368
(3032080) INR in Blood by Coagulation assay
550
4600
1.35
6.15
12.6
11.3
inr
1.2
1.4
1.84
147
1261
(3026782) Osmolality of Urine
290
2204
1.41
5.85
3.8
3.0
mosm/kgh2o
520.7
556.8
2.64
259
1881
(3002032) Base excess in Venous blood by calculation
160
1085
1.54
5.76
6.5
3.5
mmol/l
0.8
2.1
4.34
122
851
(40768446) Kidney Pathology biopsy report
12
24
5.04
5.75
1.1
1.7
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
436
3564
1.34
5.54
5.7
3.4
mmol/l
2.4
2.3
2.16
386
3052
(3037467) Urinalysis macro (dipstick) panel - Urine
750
6623
1.32
5.53
5.7
4.6
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
286
2188
1.40
5.52
6.2
4.0
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
700
7842
0.76
5.41
25.1
19.0
%
37.8
38.6
0.99
412
4873
(3009508) Creatinine [Moles/volume] in Urine
393
3173
1.35
5.39
3.8
3.1
mmol/l
6.9
7.3
0.84
327
2595
(3026008) Bacteria identified in Urine by Culture
404
3279
1.34
5.34
3.5
3.6
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
386
3120
1.34
5.23
3.9
3.2
mg/l
409.7
301.1
0.23
267
2003
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
822
8993
0.75
5.22
5.5
5.3
mmol/l
2.5
2.6
0.96
741
8049
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
67
370
1.86
5.22
1.2
1.3
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
158
1093
1.51
5.19
6.1
3.5
kpa
5.7
5.8
0.52
153
1057
(3023368) Bacteria identified in Blood by Culture
397
3243
1.33
4.96
5.1
4.4
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
679
5968
1.30
4.91
6.2
4.8
mmol/l
7.0
6.9
0.54
653
5625
(3022313) Gas panel - Capillary blood
87
530
1.69
4.87
5.2
3.8
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
244
1853
1.39
4.87
3.3
2.9
e6/l
0.7
1.1
1.76
157
1111
(3000963) Hemoglobin [Mass/volume] in Blood
920
9879
0.75
4.86
39.6
25.6
g/l
130.0
132.9
5.93
903
9658
(3010813) Leukocytes [#/volume] in Blood
920
9878
0.75
4.85
39.5
25.5
e9/l
7.1
6.9
1.09
891
9511
(3026361) Erythrocytes [#/volume] in Blood
920
9876
0.75
4.82
39.5
25.5
e12/l
4.4
4.4
1.17
892
9514
(3024731) MCV [Entitic volume]
920
9875
0.75
4.81
39.2
25.4
fl
91.4
91.8
1.77
901
9659
(3035941) MCH [Entitic mass]
920
9875
0.75
4.81
39.2
25.4
pg
30.1
30.5
5.66
901
9657
(3007461) Platelets [#/volume] in Blood
920
9874
0.75
4.79
39.4
25.5
e9/l
239.3
238.6
0.11
894
9550
(40760892) CBC W Ordered Manual Differential panel - Blood
242
1844
1.39
4.73
4.3
4.5
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
86
530
1.67
4.63
8.5
3.7
mmol/l
23.0
24.2
3.84
73
479
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
106
689
1.59
4.61
5.5
3.7
mmol/l
0.8
2.0
2.30
74
519
(3020682) Albumin/Creatinine [Ratio] in Urine
401
3308
1.31
4.61
4.7
3.9
mg/mmol
25.9
9.3
3.72
274
2104
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
801
8743
0.77
4.60
5.1
4.7
mmol/l
4.4
4.4
0.62
727
7893
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
20
70
2.89
4.50
1.3
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
20
71
2.85
4.40
1.3
1.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
70
415
1.73
4.35
1.3
1.2
iu/ml
126.0
153.3
0.28
19
151
(3002256) Pathology report gross observation
171
1250
1.43
4.24
1.3
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
795
8651
0.78
4.21
5.0
4.6
mmol/l
1.4
1.4
4.93
719
7729
(3009343) pH of Capillary blood
108
721
1.54
4.20
5.6
3.7
ph
7.4
7.4
0.31
14
90
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
9
13
6.96
4.16
10.2
9.8
mmol/l
4.8
6.6
—
9
13
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
70
422
1.70
4.11
2.3
2.5
u/ml
0.4
0.4
0.07
37
247
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
94
612
1.58
4.08
7.6
8.7
mmol/l
23.1
24.4
4.54
87
565
(3049717) Cytology report of Urine Cyto stain
83
527
1.61
4.00
2.5
2.9
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
16
53
3.04
3.97
1.4
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
16
53
3.04
3.97
1.4
1.4
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
37
184
2.04
3.96
4.4
5.4
iu/ml
85.0
355.8
—
5
25
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
25
108
2.34
3.77
2.4
1.3
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
541
4740
1.25
3.61
6.1
5.6
e9/l
0.2
0.2
2.13
467
4110
(3023323) Follitropin [Units/volume] in Serum or Plasma
26
117
2.25
3.59
1.4
1.3
iu/l
57.9
29.5
2.50
18
101
(3006315) Basophils [#/volume] in Blood
524
4585
1.24
3.51
6.0
5.4
e9/l
0.0
0.0
0.70
458
3908
(3019198) Lymphocytes [#/volume] in Blood
532
4666
1.24
3.48
6.3
5.5
e9/l
1.8
1.9
0.26
464
4063
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
796
8586
0.80
3.43
7.7
6.4
mmol/mol
41.8
41.0
1.46
732
7783
(3001604) Monocytes [#/volume] in Blood
520
4571
1.23
3.27
6.0
5.4
e9/l
0.6
0.6
0.11
452
3880
(1761868) Lipid panel - Serum or Plasma
208
2601
0.76
3.25
3.2
3.2
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
25
116
2.18
3.23
2.4
1.3
nmol/l
0.6
0.6
0.08
25
108
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
160
1216
1.36
3.17
2.6
4.0
ug/l
7.3
21.7
1.26
130
1026
(3003338) MCHC [Mass/volume]
661
7220
0.82
2.98
35.3
23.2
g/l
329.7
331.5
5.03
650
7137
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
436
3803
1.22
2.87
2.6
2.2
nmol/l
81.2
78.4
1.15
393
3292
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
903
9550
0.81
2.87
16.5
11.1
u/l
30.1
25.1
0.45
865
9125
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
780
8367
0.82
2.84
4.6
4.2
mmol/l
1.5
1.3
9.17
699
7418
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
143
1088
1.35
2.82
3.0
2.5
ug/l
4.2
6.5
3.02
124
931
(3002385) Erythrocyte distribution width [Ratio]
671
7298
0.83
2.81
29.3
21.2
%
14.2
14.0
3.57
652
7112
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
10
6.02
2.70
1.8
5.1
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
79
546
1.48
2.69
3.9
2.4
%
0.6
0.6
0.03
79
529
(3018677) aPTT in Platelet poor plasma by Coagulation assay
209
1692
1.28
2.66
2.1
2.0
s
30.4
30.0
0.39
209
1634
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
16
67
2.41
2.63
8.8
5.3
u/ml
59.8
26.8
—
5
23
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
231
1896
1.27
2.63
1.8
1.9
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
13
49
2.67
2.62
10.8
6.6
—
—
—
0
0
(4133840)
7
15
4.69
2.60
1.3
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
33
185
1.80
2.58
1.3
1.7
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
22
107
2.07
2.58
2.4
1.2
nmol/l
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
23
115
2.02
2.51
5.6
2.8
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
12
45
2.68
2.45
2.0
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
36
211
1.73
2.44
1.7
1.4
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
918
9645
0.82
2.42
32.5
20.9
mmol/l
4.1
4.0
24.54
891
9350
(3030981) Hyaline casts [#/volume] in Urine by Automated count
87
631
1.41
2.33
3.9
2.8
e6/l
0.2
0.3
0.33
87
616
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
253
2129
1.24
2.31
5.4
3.2
mmol/l
2.5
2.5
4.87
225
1857
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
198
2393
0.80
2.30
1.7
1.6
mmol/l
1.6
1.3
2.64
167
1965
(3000492) Spirometry study
50
749
0.65
2.30
1.5
1.5
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
24
127
1.91
2.27
1.5
2.2
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
918
9627
0.83
2.26
32.4
20.7
mmol/l
139.1
139.6
5.17
893
9345
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
42
264
1.61
2.22
1.2
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
9
29
3.12
2.22
2.6
1.4
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
5
9
5.57
2.21
1.0
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
212
1758
1.25
2.21
3.7
3.1
e6/l
2.1
1.9
0.13
126
1024
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
13
54
2.42
2.20
2.0
2.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
38
234
1.64
2.18
4.1
2.8
—
—
—
0
0
(40758558) Short blood count panel - Blood
276
2360
1.22
2.15
10.3
6.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
19
358
0.52
2.14
1.3
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
40
253
1.60
2.08
1.3
1.6
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
76
553
1.40
2.03
5.4
3.8
%
52.6
47.1
1.07
76
545
(3006922) Hepatitis E virus Ab [Presence] in Serum
10
38
2.64
2.01
1.1
1.0
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
43
281
1.55
1.97
1.4
1.4
ug/g
238.6
277.0
0.59
25
169
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
42
273
1.56
1.97
2.5
2.4
ug/min
242.7
81.4
1.19
28
164
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
164
1340
1.26
1.95
1.7
1.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
98
748
1.34
1.95
2.2
1.5
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
28
165
1.71
1.92
1.6
1.5
iu/l
3.0
5.7
—
10
48
(3014765) Yersinia sp identified in Stool by Organism specific culture
41
267
1.55
1.91
1.2
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
38
244
1.57
1.88
1.3
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
17
86
1.99
1.85
1.2
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
17
86
1.99
1.85
1.2
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
17
86
1.99
1.85
1.2
1.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
280
2433
1.19
1.84
4.8
3.9
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
41
270
1.54
1.83
1.2
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
807
8498
0.86
1.81
25.7
16.6
ml/min/173m2
59.6
72.9
49.85
724
7058
(3006184) Hemoglobin [Mass/volume] in Capillary blood
37
239
1.56
1.80
3.5
2.3
g/l
127.9
127.9
0.00
27
180
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
776
8194
0.86
1.80
7.1
4.6
mu/l
2.1
2.2
0.24
711
7269
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
230
1967
1.21
1.79
1.6
1.7
mg/l
1.3
1.4
0.32
175
1553
(3052851) Hemolysis interference index of Serum or Plasma
46
313
1.49
1.77
3.0
3.6
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
6
18
3.34
1.74
2.7
2.8
u/l
502.7
4611.3
—
6
18
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
218
2535
0.83
1.73
3.2
3.3
ug/l
0.9
0.8
0.20
167
1784
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
17
89
1.92
1.70
1.1
1.2
u/ml
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
122
1504
0.79
1.70
1.3
1.5
g/l
2.4
2.8
1.32
70
848
(3020630) Protein [Mass/volume] in Serum or Plasma
124
999
1.27
1.69
2.8
2.9
g/l
65.7
66.0
0.13
115
904
(3037756) Immunofixation for Serum or Plasma
41
276
1.50
1.68
1.2
1.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
58
418
1.41
1.68
2.0
1.8
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
90
696
1.32
1.67
1.6
1.5
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
23
134
1.73
1.66
2.7
2.6
mg/l
13.0
23.1
—
6
37
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
26
157
1.67
1.66
1.5
1.3
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
6
19
3.17
1.66
1.0
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
44
302
1.47
1.65
1.8
3.8
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
891
9287
0.86
1.62
25.6
16.8
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
12
56
2.15
1.61
2.2
1.6
u/field
1.2
3.7
—
5
37
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
36
238
1.53
1.61
1.3
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
18
99
1.83
1.57
1.4
1.8
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
25
152
1.66
1.57
1.3
1.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
160
1343
1.22
1.52
1.7
1.8
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
5
15
3.34
1.52
1.2
1.3
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
29
185
1.58
1.52
1.4
1.4
e6/l
2125.1
1458.5
0.31
24
135
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
75
575
1.32
1.50
1.7
1.8
g/l
1.8
1.6
1.33
62
495
(3035880) pH of Pleural fluid
15
79
1.91
1.49
1.1
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
21
124
1.70
1.47
2.0
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
92
728
1.28
1.47
2.2
1.6
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
58
430
1.37
1.45
2.5
3.2
u/ml
45202.6
3454.6
0.46
50
360
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
56
413
1.37
1.45
2.7
2.8
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
21
125
1.69
1.44
2.0
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
410
4472
0.88
1.41
2.1
2.1
pmol/l
94.0
92.2
0.33
217
2331
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
21
126
1.68
1.40
2.0
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
21
126
1.68
1.40
2.0
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
21
126
1.68
1.40
2.0
1.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
22
134
1.65
1.39
1.7
1.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
22
134
1.65
1.39
1.3
1.4
u/ml
112.8
143.5
—
6
21
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
22
134
1.65
1.39
1.3
1.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
17
96
1.78
1.39
1.3
1.3
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
35
239
1.48
1.38
3.9
2.5
%
16.9
15.6
1.37
21
121
(3045414) Leukocytes [Presence] in Urine
54
400
1.37
1.37
2.7
2.0
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
21
127
1.66
1.37
2.0
1.5
—
—
—
0
0
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
6
23
2.62
1.37
1.2
1.1
u/l
4280.8
18.0
—
6
16
(3004588) Protein electrophoresis panel - Serum or Plasma
103
837
1.25
1.34
2.0
2.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
138
1159
1.21
1.33
1.9
1.7
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
74
578
1.30
1.32
4.3
3.1
e9/l
4.1
4.2
0.13
59
425
(3034891) Synovial lining cells/100 cells in Synovial fluid
0
41
0.00
1.31
0.0
1.3
—
3.3
—
0
10
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
28
414
0.67
1.31
2.4
1.8
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
350
3176
1.14
1.30
2.2
2.2
u/l
147.2
239.0
2.15
328
2957
(3025941) Bacteria identified in Stool by Culture
60
457
1.33
1.29
1.4
1.3
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
35
2.29
1.27
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
35
2.29
1.27
1.0
1.0
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
56
424
1.34
1.26
1.3
1.2
u/ml
119.3
191.4
1.19
45
381
(3013707) Erythrocyte sedimentation rate by Westergren method
728
6918
1.12
1.25
5.1
4.1
mm/h
18.4
14.5
5.12
668
6281
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
22
139
1.59
1.23
1.2
1.5
—
—
—
0
0
(3024471) HLA-A [Type]
5
19
2.64
1.21
1.0
1.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
141
1649
0.84
1.21
1.2
1.2
u/ml
0.7
1.7
2.33
35
400
(3001122) Ferritin [Mass/volume] in Serum or Plasma
417
3842
1.13
1.21
3.7
2.8
ug/l
233.8
159.5
3.63
373
3445
(3026389) Candida sp identified in Specimen by Organism specific culture
18
109
1.66
1.19
1.7
1.4
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
6
26
2.31
1.18
1.2
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
24
157
1.54
1.17
1.1
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
16
94
1.71
1.17
1.4
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
26
174
1.50
1.15
1.3
1.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
35
249
1.42
1.15
5.4
4.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
135
1149
1.20
1.15
3.8
3.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
46
344
1.35
1.14
1.2
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
16
95
1.69
1.14
1.5
1.8
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
54
414
1.32
1.13
2.4
3.6
mg/l
65.7
70.8
0.11
46
340
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
54
414
1.32
1.13
2.4
3.6
mg/l
50.4
74.2
0.36
46
344
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
107
892
1.22
1.13
7.5
3.8
mmol/l
1.2
1.2
0.30
99
763
(3024928) Oxygen saturation in Venous blood
35
251
1.41
1.11
3.5
2.5
—
—
—
0
0
(3019225) pH of Specimen
124
1053
1.20
1.09
10.7
4.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
23
152
1.52
1.09
1.3
1.5
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
12
66
1.83
1.09
1.7
3.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
58
453
1.29
1.08
2.1
1.9
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
351
3222
1.12
1.08
6.3
5.4
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
117
992
1.20
1.05
2.2
2.1
g/l
0.2
0.2
2.02
105
921
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
327
3559
0.89
1.05
4.8
4.7
%
23.1
21.7
0.85
184
1851
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
18
275
0.65
1.02
1.8
1.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
311
2846
1.12
1.00
2.4
2.2
mg/l
3.6
3.2
2.26
263
2396
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
110
0.45
1.00
1.2
1.0
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
24
164
1.47
0.99
1.4
1.4
e6/l
184771.5
72260.6
0.37
17
100
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
415
4445
0.90
0.99
5.3
5.4
ug/l
5.7
4.5
0.26
369
3905
(3012441) Differential panel - Pleural fluid
23
156
1.48
0.99
1.4
1.4
—
—
—
0
0
(44813793)
9
49
1.84
0.98
1.1
1.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
22
319
0.68
0.98
1.1
1.0
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
29
0.00
0.97
0.0
1.2
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
0
29
0.00
0.97
0.0
1.3
—
137.0
—
0
22
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
24
165
1.46
0.97
1.4
1.4
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
22
318
0.69
0.97
1.1
1.1
—
111.8
—
0
6
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
19
124
1.54
0.97
1.3
1.6
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
11
185
0.59
0.94
1.2
1.5
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
44
338
1.31
0.94
5.7
6.1
mmol/l
1.2
1.4
0.55
37
298
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
11
62
1.78
0.94
1.3
1.3
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
11
62
1.78
0.94
1.8
1.6
—
38.0
—
0
10
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
16
101
1.59
0.93
3.9
2.2
u/field
0.6
2.0
—
5
31
(3022096) Basophils/100 leukocytes in Blood
450
4218
1.10
0.93
6.4
5.6
%
0.6
0.6
0.01
428
3899
(46235355) HIV 1 and 2 tests - Meaningful Use set
102
869
1.19
0.90
2.2
1.6
—
—
—
0
0
(3017704) Immunofixation for Urine
13
79
1.65
0.88
1.2
1.8
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
21
144
1.47
0.87
1.8
2.4
—
1598.8
—
0
14
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
65
789
0.81
0.87
1.7
1.8
%
1.5
1.6
0.66
55
649
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
11
64
1.72
0.86
2.0
2.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
120
1042
1.17
0.85
3.0
2.5
e9/l
63.9
68.3
0.94
95
824
(44806118)
17
112
1.52
0.85
1.3
1.4
—
—
—
0
0
(44790047)
17
112
1.52
0.85
1.3
1.4
—
—
—
0
0
(44790048)
17
112
1.52
0.85
1.3
1.4
—
—
—
0
0
(44790049)
17
112
1.52
0.85
1.3
1.4
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
469
4423
1.10
0.84
6.6
5.8
%
24.7
25.8
1.19
443
4071
(3042631) Mycobacterium sp identified in Specimen
23
162
1.43
0.84
3.0
2.8
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
461
4345
1.10
0.84
6.8
5.9
%
8.7
9.0
1.07
440
4021
(3021440) Promyelocytes/100 leukocytes in Blood
90
764
1.19
0.84
4.1
4.2
%
0.2
0.1
0.56
31
244
(3002179) Metamyelocytes/100 leukocytes in Blood
85
723
1.19
0.78
4.0
4.0
%
0.8
0.6
0.30
22
194
(3002331) Protein [Mass/volume] in Peritoneal fluid
0
26
0.00
0.78
0.0
1.7
—
28.9
—
0
20
(3006504) Eosinophils/100 leukocytes in Blood
458
4328
1.09
0.78
6.4
5.6
%
3.1
2.8
1.09
436
3992
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
99
0.50
0.77
1.2
1.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
95
817
1.18
0.77
4.0
4.1
%
0.9
0.9
0.00
33
267
(40768806) Pleura Pathology biopsy report
22
157
1.41
0.77
1.5
1.6
—
—
—
0
0
(3012501) Base excess in Blood by calculation
34
261
1.31
0.77
5.6
4.8
mmol/l
2.7
2.7
0.02
23
182
(40768800) Prostate Pathology biopsy report
22
302
0.72
0.76
1.2
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
11
67
1.65
0.75
2.0
2.2
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
9
54
1.67
0.74
3.7
1.7
—
47.5
—
0
5
(3008757) Leukocyte morphology finding [Identifier] in Blood
18
125
1.45
0.72
2.9
4.6
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
457
4333
1.09
0.71
6.3
5.6
%
59.6
58.8
0.71
435
4012
(3032057) Clostridioides difficile [Presence] in Stool
5
26
1.93
0.70
1.2
1.9
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
9
58
1.56
0.70
1.3
1.6
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
10
61
1.64
0.68
3.6
4.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
27
1.85
0.68
1.0
1.0
miu/ml
909.2
1728.4
—
5
27
(3024980) IgG subclass 4 [Mass/volume] in Serum
7
118
0.59
0.68
1.3
1.5
g/l
0.6
0.8
—
7
89
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
5
93
0.54
0.67
1.0
1.3
%
15.9
28.0
—
5
64
(4281824)
14
94
1.49
0.66
1.1
1.2
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
5
28
1.79
0.66
1.4
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
32
250
1.29
0.66
1.5
1.4
—
—
—
0
0
(1002224) Polysomnography panel
18
248
0.72
0.66
1.0
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
10
62
1.62
0.65
1.0
1.1
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
311
2915
1.09
0.64
3.7
3.2
u/l
34.7
35.3
0.07
295
2770
(3042111) Morphology [Interpretation] in Bone marrow Narrative
15
212
0.70
0.64
1.5
1.5
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
10
63
1.59
0.61
2.0
2.7
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
83
723
1.16
0.61
4.3
4.2
%
0.4
0.6
0.14
26
208
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
8
51
1.57
0.60
1.3
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
52
1.54
0.59
1.0
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
442
4214
1.07
0.59
5.1
4.2
ng/l
56.6
55.2
0.03
368
3264
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
21
157
1.34
0.59
1.3
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
39
318
1.23
0.58
2.1
1.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
55
466
1.19
0.57
1.3
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
70
805
0.86
0.57
1.3
1.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
198
2138
0.91
0.56
4.7
4.1
ng/l
258.8
325.2
0.29
169
1838
(3023410) Appearance of Cerebral spinal fluid
5
87
0.57
0.56
1.2
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
11
160
0.68
0.56
1.3
1.4
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
6
37
1.62
0.55
1.0
1.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
6
37
1.62
0.55
1.5
2.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
8
125
0.64
0.54
1.3
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
66
757
0.86
0.53
1.3
1.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
380
3619
1.07
0.52
3.6
3.2
ng/l
2868.6
1903.5
1.97
343
3145
(40768797) Stomach Pathology biopsy report
139
1268
1.11
0.52
1.3
1.2
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
51
434
1.18
0.52
1.9
2.7
g/l
3.4
3.2
0.55
37
335
(3019309) Folate [Moles/volume] in Red Blood Cells
221
2364
0.92
0.52
1.7
1.8
nmol/l
1369.4
1174.0
1.85
164
1766
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
21
270
0.77
0.51
1.8
1.5
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
11
157
0.70
0.51
1.4
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
15
109
1.38
0.51
2.7
3.4
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
6
41
1.47
0.50
1.5
1.2
ug/l
6.4
6.5
—
6
35
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
45
1.56
0.49
1.0
1.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
38
317
1.20
0.48
1.6
1.6
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
47
549
0.85
0.48
2.2
1.8
g/l
2.4
1.6
0.49
37
498
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
13
93
1.40
0.48
1.3
1.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
114
1035
1.11
0.48
1.3
1.3
titre
705.5
455.2
0.36
22
240
(3000330) Specific gravity of Urine by Test strip
49
569
0.86
0.47
4.8
4.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
31
254
1.23
0.47
4.4
3.6
mg/l
24.3
28.6
0.24
15
171
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
25
200
1.25
0.46
2.0
1.2
u/l
57.7
46.5
0.12
18
174
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
16
120
1.34
0.46
1.4
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
7
49
1.43
0.46
1.3
1.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
7
49
1.43
0.46
1.3
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
7
49
1.43
0.46
1.3
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
7
49
1.43
0.46
1.3
1.9
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
50
577
0.86
0.45
1.2
1.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
164
1522
1.09
0.45
2.0
2.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
10
69
1.45
0.44
2.6
3.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
16
121
1.33
0.44
1.3
1.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
101
917
1.11
0.43
2.6
2.3
u/l
165.5
32.7
0.51
88
768
(44816559) Phosphatidylethanol [Mass/volume] in Blood
10
140
0.71
0.43
1.1
1.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
896
9113
0.94
0.43
25.2
17.4
mg/l
32.2
27.8
2.74
797
7487
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
8
57
1.41
0.42
1.5
2.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
8
58
1.38
0.41
1.4
1.6
—
—
—
0
0
(4015189)
5
33
1.52
0.41
4.2
2.3
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
12
161
0.74
0.41
1.0
1.1
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.2
—
36.3
—
0
16
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
17
0.00
0.40
0.0
2.7
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
2.5
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
46
399
1.16
0.40
1.9
2.9
g/l
1.5
1.5
0.01
41
341
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
123
1134
1.09
0.40
3.1
2.7
umol/l
9.8
10.1
0.04
107
989
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
18
0.00
0.40
0.0
2.6
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
0
18
0.00
0.40
0.0
1.1
—
87.0
—
0
13
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
0
18
0.00
0.40
0.0
1.8
—
89.8
—
0
13
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
14
182
0.77
0.39
1.0
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
35
1.43
0.39
1.0
1.3
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
7
106
0.66
0.39
1.0
1.1
—
43.9
—
0
20
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
19
0.00
0.39
0.0
1.6
—
1.2
—
0
19
(3045788) Cell count panel - Pleural fluid
18
142
1.27
0.38
1.5
1.4
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
9
67
1.35
0.38
1.0
1.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
422
4079
1.05
0.36
12.8
10.3
e9/l
0.0
0.0
1.32
346
3307
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
9
122
0.74
0.35
2.7
3.5
—
—
—
0
0
(4146454)
9
122
0.74
0.35
2.1
2.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
31
264
1.18
0.35
1.2
1.4
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
27
319
0.84
0.34
3.0
3.2
nmol/l
0.8
0.9
0.57
19
246
(3039443) Prostate specific Ag panel - Serum or Plasma
13
166
0.78
0.33
1.6
1.7
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
262
2736
0.95
0.33
1.7
1.6
nmol/l
19.2
20.2
0.47
232
2307
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
53
473
1.13
0.33
1.9
2.6
g/l
3.8
3.8
0.04
36
328
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
88
0.68
0.33
1.0
1.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
151
1420
1.07
0.32
2.8
2.4
%
1.7
1.8
0.33
136
1259
(3023419) Bacteria identified in Sputum by Culture
19
155
1.23
0.32
3.2
2.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
53
474
1.12
0.32
1.9
2.6
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
53
474
1.12
0.32
1.9
2.6
g/l
7.5
7.5
0.06
37
340
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
11
83
1.33
0.32
1.3
1.7
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
24
284
0.84
0.32
3.6
3.3
mmol/l
1.9
1.6
0.53
24
277
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
137
1285
1.07
0.32
1.2
1.2
u/ml
13.6
14.2
0.04
61
445
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
7
52
1.35
0.31
2.9
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
7
52
1.35
0.31
2.9
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
7
96
0.73
0.31
1.1
1.1
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
18
147
1.23
0.30
2.0
1.9
%
89.5
89.6
0.02
18
147
(3000012) Reticulocyte production index
7
54
1.30
0.30
1.1
1.8
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
100
1074
0.92
0.29
3.1
3.1
ng/l
348.2
254.9
0.86
93
985
(3038515) Glucose [Moles/volume] in Venous blood
23
269
0.85
0.28
3.7
3.4
mmol/l
7.5
7.8
0.16
23
263
(3033658) Prothrombin time (PT) actual/Normal
262
2521
1.05
0.27
4.8
4.0
%
89.1
84.0
2.30
256
2460
(3044927) Protein electrophoresis panel - Urine
17
140
1.22
0.27
1.5
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
8
64
1.25
0.27
1.1
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
47
521
0.90
0.27
1.4
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
28
243
1.16
0.27
1.2
1.2
—
—
—
0
0
(4062490)
5
71
0.70
0.26
1.0
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
72
0.69
0.26
1.4
1.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
10
77
1.30
0.26
1.0
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
26
225
1.16
0.26
2.2
1.6
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
63
685
0.92
0.26
2.9
2.7
g/l
10.3
10.9
0.46
52
621
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
30
263
1.14
0.25
1.4
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
30
263
1.14
0.25
1.4
1.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
10
127
0.79
0.25
1.3
1.3
—
—
—
0
0
(3013512) EKG study
325
3150
1.04
0.25
5.0
4.3
—
—
—
0
0
(3048879) Bone marrow aspiration report
5
38
1.32
0.23
1.8
1.7
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
38
1.32
0.23
1.4
2.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
38
1.32
0.23
1.4
2.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
13
106
1.23
0.23
1.4
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
668
6783
0.97
0.23
5.2
4.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
39
1.28
0.23
1.2
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
39
1.28
0.23
1.4
2.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
39
1.28
0.23
1.4
1.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
25
219
1.14
0.22
1.4
1.6
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
5
41
1.22
0.22
1.6
1.3
%
30.8
27.6
—
5
29
(3022621) pH of Urine by Test strip
71
662
1.08
0.21
4.2
3.3
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
75
701
1.07
0.21
2.5
2.2
nmol/l
11.8
12.2
0.10
64
608
(3016330) Potassium [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
6
48
1.25
0.20
1.2
1.3
mmol/l
2.4
3.5
—
6
42
(3017315) Amylase [Enzymatic activity/volume] in Urine
6
49
1.23
0.20
1.0
1.2
u/l
177.7
407.4
—
6
44
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
6
51
1.18
0.19
1.3
1.8
nmol/l
18.2
16.5
—
6
45
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
53
491
1.08
0.19
4.8
4.7
%
1.6
1.7
0.47
48
463
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
52
1.15
0.19
1.7
2.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
78
735
1.06
0.19
1.8
1.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
54
580
0.93
0.18
2.6
2.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
20
227
0.88
0.18
2.5
2.3
—
—
—
0
0
(3024263) Appearance of Synovial fluid
7
58
1.21
0.18
1.4
1.5
—
—
—
0
0
(4010399)
71
668
1.07
0.18
1.4
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
17
147
1.16
0.18
1.0
1.1
—
—
—
0
0
(3036489) Thrombin time
35
319
1.10
0.18
1.5
2.0
s
25.0
21.9
0.71
30
294
(4094501)
26
233
1.12
0.17
1.1
1.1
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
7
61
1.15
0.17
1.1
1.2
—
38.4
—
0
5
(3024139) IgG subclass 3 [Mass/volume] in Serum
5
69
0.72
0.17
1.0
1.2
g/l
0.4
0.4
—
5
48
(3028192) IgG subclass 2 [Mass/volume] in Serum
5
69
0.72
0.17
1.0
1.2
g/l
2.9
2.8
—
5
50
(3027135) IgG subclass 1 [Mass/volume] in Serum
5
69
0.72
0.17
1.0
1.2
g/l
7.3
7.6
—
5
50
(40768441) Liver Pathology biopsy report
8
68
1.18
0.16
1.5
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
228
2217
1.03
0.16
1.4
1.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
70
1.14
0.16
1.4
1.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
14
162
0.86
0.16
1.1
1.1
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
6
77
0.78
0.15
4.2
2.5
mmol/l
7.5
7.2
—
6
45
(3014271) Vancomycin [Susceptibility]
6
78
0.77
0.15
3.2
2.8
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
23
255
0.90
0.15
1.3
1.9
—
—
—
0
0
(40768443) Skin Pathology biopsy report
39
420
0.93
0.15
1.2
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
11
129
0.85
0.14
1.0
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
7
89
0.79
0.14
1.0
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
31
285
1.09
0.14
1.5
1.6
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
10
84
1.19
0.14
1.2
2.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
436
4293
1.02
0.14
2.4
2.4
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
47
441
1.07
0.13
2.0
2.7
g/l
10.2
10.7
0.29
38
371
(3000093) Morphology [Interpretation] in Blood Narrative
8
97
0.82
0.13
1.0
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
106
1020
1.04
0.13
1.3
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
30
277
1.08
0.12
1.2
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
114
1101
1.04
0.12
1.5
1.4
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
13
114
1.14
0.11
1.8
1.9
—
—
—
0
0
(4024509)
11
95
1.16
0.11
1.3
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
28
259
1.08
0.11
1.3
1.5
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
173
1688
1.03
0.11
30.4
29.3
inr
1.6
1.4
0.64
19
216
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
86
1.16
0.11
1.0
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
539
5444
0.98
0.10
3.4
3.2
u/l
55.6
55.7
0.00
484
4942
(3033705) Calcium.ionized [Moles/volume] in Venous blood
19
173
1.10
0.10
2.9
2.7
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
242
2378
1.02
0.09
1.7
1.8
pmol/l
443.1
11948479.1
1.30
202
1925
(40761536) Microorganisms panel - Urine sediment
85
822
1.04
0.09
5.7
4.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
119
1220
0.97
0.09
4.8
4.7
%
31.2
32.4
0.61
83
776
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
38
361
1.05
0.08
1.6
1.9
u/l
33.9
38.1
0.63
33
313
(3008898) HLA-B27 [Presence]
17
185
0.92
0.08
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
60
0.83
0.08
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
60
0.83
0.08
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
60
0.83
0.08
1.2
1.1
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
5
61
0.82
0.08
1.0
1.1
mg/l
40.6
42.8
—
5
54
(3051593) INR in Capillary blood by Coagulation assay
5
63
0.79
0.08
11.8
14.0
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
6
71
0.84
0.07
1.0
1.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
6
72
0.83
0.07
1.0
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
661
6649
0.99
0.07
6.4
3.7
pmol/l
15.4
15.1
3.04
612
5870
(3044242) Glucose [Moles/volume] in Arterial blood
8
78
1.03
0.07
1.8
2.5
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
7
81
0.86
0.07
1.1
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
7
83
0.84
0.07
1.7
1.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
9
86
1.05
0.07
1.6
1.5
%
11.7
10.8
—
9
86
(1761482) Bacteria [#/volume] in Urine by Culture
32
336
0.95
0.07
6.3
5.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
9
103
0.87
0.06
1.1
1.3
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
27
256
1.06
0.06
1.7
1.6
iu/ml
0.3
21.9
—
9
55
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
133
1350
0.98
0.05
1.3
1.3
iu/ml
19.4
38.5
3.56
39
419
(3048929) Epstein Barr virus Ab [Presence] in Serum
19
179
1.06
0.04
1.1
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
17
180
0.94
0.04
1.2
1.3
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
20
191
1.05
0.03
4.0
3.1
%
59.0
60.0
0.11
20
191
(3001019) Free T4 and TSH panel - Serum or Plasma
20
191
1.05
0.03
1.5
1.6
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
86
848
1.01
0.02
1.9
2.2
ug/g
106.1
151.2
1.33
66
661
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
18
188
0.96
0.02
1.5
1.6
—
—
—
0
0
(4306422)
10
93
1.08
0.02
1.1
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
16
153
1.05
0.01
1.1
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
32
315
1.02
0.00
1.3
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
16
156
1.03
0.00
1.4
1.3
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
37
366
1.01
0.00
2.0
2.7
g/l
34.8
36.8
0.96
32
310
(4034850)
31
312
0.99
0.00
18.0
13.4
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
25
249
1.00
0.00
1.5
3.0
umol/l
25.6
35.4
4.21
17
199
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
19
187
1.02
0.00
1.4
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
91
905
1.01
0.00
1.3
1.3
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
5
58
0.86
0.00
2.0
1.7
mmol/l
8.6
9.2
—
5
47
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
7
0.00
0.00
0.0
7.4
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
39.4
—
0
5
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
6
0.00
0.00
0.0
2.0
—
1.9
—
0
6
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
6
65
0.92
0.00
1.8
1.6
umol/l
18.2
14.8
—
6
60
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
21.6
—
0
5
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3004451) EKG impression Narrative
6
68
0.88
0.00
1.2
1.2
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
2.6
—
0
5
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
3.1
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
59
0.85
0.00
1.2
1.1
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
7
77
0.91
0.00
1.0
1.1
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
5.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
55
0.91
0.00
1.0
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
7
75
0.93
0.00
1.0
1.1
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
59
0.85
0.00
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
59
0.85
0.00
1.2
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007916) DNA double strand Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
57
0.88
0.00
1.0
1.3
nmol/l
119.4
139.4
—
5
57
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
7.8
—
0
5
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
7
71
0.99
0.00
1.0
2.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
67
0.89
0.00
1.5
1.1
—
—
—
0
0
(3013762) Body weight Measured
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.5
—
449.7
—
0
6
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
93.3
—
0
9
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
6
62
0.97
0.00
1.0
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
6
60
1.00
0.00
1.3
1.6
—
—
—
0
0
(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
5
56
0.89
0.00
1.0
1.0
—
3.6
—
0
22
(3003740) Influenza virus B Ag [Presence] in Specimen
7
75
0.93
0.00
1.0
1.1
—
—
—
0
0

Mortality – FinRegistry

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

Index endpoint: C3_RENAL_CELL_CARCINOMA – Renal cell carcinoma of kidney

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).